Reuters logo
in 10 months
BRIEF-OSE Immunotherapeutics to present preclinical data of its new checkpoint inhibitor
October 4, 2016 / 3:51 PM / in 10 months

BRIEF-OSE Immunotherapeutics to present preclinical data of its new checkpoint inhibitor

1 Min Read

Oct 4 (Reuters) - OSE Immunotherapeutics SA :

* To present the preclinical data of its new checkpoint inhibitor EFFI-dem on SIRP-/cd47 strategic pathway at the 2016 immune checkpoint inhibitors conference Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below